Sunesis Pharmaceuticals (SNSS) Misses Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q3 EPS of ($0.25), $0.08 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $854 thousand versus the consensus estimate of $1.97 million.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Kepler Cheuvreux Starts Swiss Re (SREN:SW) (SSREY) at Reduce
- Morgan Stanley Downgrades Group 1 Automotive Inc. (GPI) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
